Feedback / Questions
dexamethasone cyclodextrin nanoparticle ophthalmic suspension (OCS-01) - Oculis
Efficacy and Safety of Dexamethasone Nanoparticles Eye Drops in Diabetic Macular Edema
(clinicaltrials.gov)
-
Apr 25, 2022 -
P2 | N=144 | Completed | Sponsor: Oculis
New P2 trial
•
Diabetic Macular Edema • Ophthalmology
http://clinicaltrials.gov/ct2/show/NCT05343156
Apr 25, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next